Article Details

Kala Pharmaceuticals (NASDAQ:KALA) Raised to Hold at Zacks Investment Research

Retrieved on: 2021-01-05 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

Kala Pharmaceuticals (NASDAQ:KALA) Raised to Hold at Zacks Investment Research. View article details on hiswai:

Excerpt

Vanguard Group Inc. now owns 2,203,116 shares of the company's stock worth $23,155,000 after buying an additional 207,266 shares during the last ...

Article found on: www.marketbeat.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up